cancer
Nanoparticle-based approaches are a promising strategy for treating colorectal cancer.
Genetic factors can influence tumor-associated microbes, offering insights into colorectal cancer progression and potential therapeutic targets.
Certain bile acids produced by gut microbes can interact with specific receptors in the body, influencing immune cells to fight tumors.
Each Fusobacterium nucleatum population has unique traits and distribution patterns across body sites and conditions such as colorectal cancer and Crohn’s disease.
Understanding the complex interactions between exercise, diet and gut health can help to develop approaches to influence the gut microbiota, boost immunity and prevent or manage gastrointestinal diseases.
Preclinical findings will be presented at the American Association for Cancer Research (AACR) Annual Meeting in Chicago.
Emil Chuang, Chief Medical Officer at Intrinsic Medicine, explores the growing understanding of gut-brain axis disorders and the potential of Human Milk Oligosaccharides (HMOs) in their treatment.
The microbiota plays a protective role against colorectal cancer by regulating Snhg9.
Probiotics such as Lactobacillus can complement breast cancer therapy to improve prevention and treatment.
Professor Maria Rescigno explores the critical role of the gut microbiota in maintaining intestinal barrier integrity and its implications for health.
